Omnipod 5 G6 Pods (Gen 5) (Insulin Pump Cart,Automated,Bt) — Medicare Part D spending
Insulet Corpora · Rank #279 by total Part D spend · CMS data year 2023
Medicare Part D spent $160,474,984 on Omnipod 5 G6 Pods (Gen 5) (Insulin Pump Cart,Automated,Bt) in 2023, the #279 drug by total Part D spending out of 3,598 drugs. That worked out to about $59.74 per dosage unit, $1,219 per claim and $5,290 per beneficiary, across 131,614 claims for 30,338 beneficiaries. Average spending per dosage unit rose +3.1% from 2022. These are aggregate Medicare program figures (gross drug cost), not the price you pay.
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
Omnipod 5 G6 Pods (Gen 5) (Insulin Pump Cart,Automated,Bt) spending at a glance (2023)
| Metric | Omnipod 5 G6 Pods (Gen 5) (Insulin Pump Cart,Automated,Bt) |
|---|---|
| Total Part D spending (2023) | $160,474,984 |
| Total spending (2022) | $29,105,567 |
| Year-over-year change in total spending | +451.4% |
| Average spending per dosage unit (2023) | $59.74 |
| Change in spend per dosage unit (YoY) | +3.1% |
| Avg annual change per dosage unit (2019-2023 CAGR) | +3.1% |
| Average spending per claim (2023) | $1,219 |
| Average spending per beneficiary (2023) | $5,290 |
| Total claims (2023) | 131,614 |
| Beneficiaries (2023) | 30,338 |
| Total dosage units (2023) | 2,686,360 |
| Manufacturer(s) | Insulet Corpora |
| National rank by total spend (of 3,598 drugs) | #279 |
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
2022 vs 2023
| Metric | 2022 | 2023 | Change |
|---|---|---|---|
| Total spending | $29,105,567 | $160,474,984 | +451.4% |
| Avg spend per dosage unit | $57.92 | $59.74 | +3.1% |
| Avg spend per claim | $1,294 | $1,219 | — |
| Avg spend per beneficiary | $2,595 | $5,290 | — |
| Total claims | 22,488 | 131,614 | — |
| Beneficiaries | 11,217 | 30,338 | — |
How Omnipod 5 G6 Pods (Gen 5) compares with nearby drugs
Drugs with total Part D spending closest to Omnipod 5 G6 Pods (Gen 5) (Insulin Pump Cart,Automated,Bt):
| Drug (rank) | Total spend 2023 | Per dosage unit | Per-unit YoY |
|---|---|---|---|
| Omnipod 5 G6 Pods (Gen 5) (Insulin Pump Cart,Automated,Bt) (this drug, #279) | $160,474,984 | $59.74 | +3.1% |
| Belsomra (Suvorexant) (#277) | $161,202,978 | $14.98 | +5.8% |
| Lacosamide* (Lacosamide) (#278) | $160,659,898 | $2.59 | -38.5% |
| Sucralfate (#280) | $160,271,432 | $0.32 | -0.5% |
| Ultomiris (Ravulizumab-Cwvz) (#281) | $159,533,070 | $2,218.03 | +14.8% |
| Panzyga (Immun Glob G(IgG)-Ifas/Glycine) (#282) | $158,695,483 | $20.85 | +3.8% |
Frequently asked questions
How much does Medicare Part D spend on Omnipod 5 G6 Pods (Gen 5)?
Medicare Part D spent $160,474,984 on Omnipod 5 G6 Pods (Gen 5) (Insulin Pump Cart,Automated,Bt) in 2023 (the latest CMS data year), across 131,614 claims for 30,338 beneficiaries. That ranks #279 of 3,598 drugs by total Part D spending. This is gross drug cost (Medicare, plan and beneficiary payments combined), not the price you personally pay.
What is the average spending per dosage unit for Omnipod 5 G6 Pods (Gen 5)?
In 2023, the weighted average Medicare Part D spending per dosage unit for Omnipod 5 G6 Pods (Gen 5) (Insulin Pump Cart,Automated,Bt) was $59.74. Compared with 2022 it rose +3.1%. A "dosage unit" is one pill, tablet, milliliter or other billing unit, so this is not the price of a prescription.
Who makes Omnipod 5 G6 Pods (Gen 5)?
CMS attributes Omnipod 5 G6 Pods (Gen 5) (Insulin Pump Cart,Automated,Bt) to Insulet Corpora in the 2023 Part D spending file. Average spending per claim was $1,219 and per beneficiary $5,290.
Is the Omnipod 5 G6 Pods (Gen 5) figure the price I pay?
No. These are aggregate Medicare Part D program figures (total gross drug cost and averages across all claims), published by CMS for transparency. Your out-of-pocket cost depends on your plan, formulary, deductible and coverage phase. Always check your plan and talk to your pharmacist or doctor.
Keep exploring
Source & what this means
Figures are from the CMS Medicare Part D Spending by Drug dataset (data year 2023, US public domain). "Total spending" is the gross drug cost — Medicare, plan and beneficiary payments combined — for Part D claims; it is not a list price, a negotiated price, or what any individual pays. Spending per dosage unit is volume-weighted across formulations. This is general public-spending information, not medical or pricing advice. Your own cost depends on your plan, deductible and coverage phase — verify with your Part D plan and a pharmacist. Data as of June 2026. See our methodology and disclaimer.
Last updated: 2026-06-20